Blocking Ca2+ Channel β3 Subunit Reverses Diabetes
Author(s) -
Kayoung Lee,
Jaeyoon Kim,
Martin Köhler,
Jia Yu,
Yue Shi,
Shao-Nian Yang,
Sung Ho Ryu,
PerOlof Berggren
Publication year - 2018
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2018.06.086
Subject(s) - blocking (statistics) , protein subunit , diabetes mellitus , channel (broadcasting) , chemistry , microbiology and biotechnology , medicine , biology , computer network , endocrinology , computer science , biochemistry , gene
Voltage-gated Ca 2+ channels (Ca v ) are essential for pancreatic beta cell function as they mediate Ca 2+ influx, which leads to insulin exocytosis. The β3 subunit of Ca v (Ca v β 3 ) has been suggested to regulate cytosolic Ca 2+ ([Ca 2+ ] i ) oscillation frequency and insulin secretion under physiological conditions, but its role in diabetes is unclear. Here, we report that islets from diabetic mice show Ca v β 3 overexpression, altered [Ca 2+ ] i dynamics, and impaired insulin secretion upon glucose stimulation. Consequently, in high-fat diet (HFD)-induced diabetes, Ca v β 3 -deficient (Ca v β 3 -/- ) mice showed improved islet function and enhanced glucose tolerance. Normalization of Ca v β 3 expression in ob/ob islets by an antisense oligonucleotide rescued the altered [Ca 2+ ] i dynamics and impaired insulin secretion. Importantly, transplantation of Ca v β 3 -/- islets into the anterior chamber of the eye improved glucose tolerance in HFD-fed mice. Ca v β 3 overexpression in human islets also impaired insulin secretion. We thus suggest that Ca v β 3 may serve as a druggable target for diabetes treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom